timothy sykes logo

Stock News

Tilray Shares Surge on Trump’s Marijuana Policy Shift

Bryce TuoheyAvatar
Written by Bryce Tuohey Reviewed by Tim Sykes Fact-checked by Matt Monaco
Updated 12/13/2025, 8:16 am ET 12/13/2025, 8:16 am ET | 5 min 5 min read
Tilray Shares Surge on Trump’s Marijuana Policy Shift Thumbnail

Tilray Brands Inc.’s stocks have been trading up by 60.5 percent amid significant investor enthusiasm in the market.

Healthcare industry expert:

Analyst sentiment – positive

Market Position & Fundamentals: Tilray Brands (TLRY), while showing potential through strong revenue with a total of $821.31 million, faces significant profitability challenges indicated by negative margins across the board, including a pretax profit margin of -139.7% and an EBIT margin of -170.5%. Despite a reasonable gross margin of 28.7%, these numbers reflect a company heavily reliant on external financing as indicated by a low debt-to-equity ratio of 0.17. The financials suggest an urgent need for operational restructuring, given the unsustainable nature of its current cost structure which outpaces revenue growth significantly.

Technical Analysis & Trading Strategy: Recent price action for TLRY shows a strong upward trend driven by impactful news, with a notable weekly high leap from $11.06 to $13.53 within five trading sessions, bolstered by surges in trading volume. Such a bullish rally indicates strong market optimism, aligning with significant upward momentum initiated around the breaking of the $8.50 resistance. For trading strategy, investors should capitalize on the break and sustain above $13.50 as a key level, employing a trailing stop strategy to capture ongoing gains while mitigating downside risk due to any potential reversal.

Catalysts & Outlook: The recent upgrade by ATB Capital and news of potential US cannabis policy changes have catalyzed a substantial rally in Tilray’s stock, with gains reported as high as 32%. The launch of new products prioritizes market expansion and could serve as a pivotal long-term growth catalyst. Compared to its peers and broader benchmarks in the Healthcare and Pharmaceuticals sectors, TLRY is uniquely positioned to benefit from regulatory easing. Current technical and macroeconomic signals point toward a bullish outlook with a price target near $15, supported by continued investor appetite and a strategic pivot towards profitability.

Candlestick Chart

Weekly Update Dec 08 – Dec 12, 2025: On Saturday, December 13, 2025 Tilray Brands Inc. stock [NASDAQ: TLRY] is trending up by 60.5%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Tilray’s recent stock activity paints a dynamic picture, marked by significant investor excitement and market momentum. In just five trading days, the stock price moved dramatically—from $7.18 to $13.53—representing an upward surge of almost 89%. This rapid ascent underscores the positive investor sentiment triggered by potential U.S. policy changes regarding cannabis.

Financially, Tilray’s performance reveals strong underlying fundamentals despite challenges. The company’s revenue stands robustly at $821.3M, though profitability remains a hurdle with a negative EBIT margin of -170.5%. However, Tilray’s gross margin of 28.7% indicates efficient production and operational management. The company’s total equity, impressively valued at $1.54B, reflects balanced financial health even with negative net income reported in its latest statements.

Trading patterns and key ratios point to optimistic market behavior. Tilray’s current ratio of 2.6 suggests strong short-term financial resilience, providing a buffer to navigate potential growth and expansion. This capacity, alongside a leverage ratio of 1.4, highlights a stable bridge between managing debt and generating future revenues.

More Breaking News

Amidst these dynamic shifts, Tilray’s stock performance continues to draw investor interest, with the prospect of eased restrictions providing both immediate and long-lasting implications.

Conclusion

In light of recent developments, Tilray Brands stands on the cusp of significant opportunity. The potential reclassification of marijuana in the United States marks a pivotal moment that could redefine market dynamics and growth trajectories for the cannabis sector.

Despite current profitability headwinds, Tilray is strategically positioned to leverage upcoming regulatory easements. A focus on operational efficiency and market expansion, coupled with an energized trader base, paves the way for future successes.

As millionaire penny stock trader and teacher Tim Sykes says, “Consistency is key in trading; don’t let emotions dictate your trades.” This aligns perfectly with Tilray’s strategic approach as the market continues to digest these changes. Tilray’s trajectory may serve as a barometer for the wider cannabis industry’s evolution in response to shifting political and economic landscapes. Traders are well-positioned to monitor these developments closely, attuned to the opportunities and challenges that lie ahead.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Bryce Tuohey

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
Bryce’s first pattern was buying into strength in breakouts. But he noticed when they didn’t work, he took bigger losses. When the OTC market got hot, Bryce learned to dip buy the inevitable panics. He adapted his breakout strategy and now buys consolidation and trend breaks. His goal is to have better risk/reward and get an entry before multi-day listed breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”